Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
SILVERARC CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 67 | 335,961,131 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
Kodiak Sciences Inc | EQUITIES | 101 | $3,040,000 | 1,000,000 | 0.00 | 0.00 | -114,461 | -10.27 | 12-31-2023 |
Biohaven Ltd | EQUITIES | 102 | $3,025,746 | 70,695 | 0.00 | 0.00 | 60,695 | 606.95 | 12-31-2023 |
MoonLake Immunotherapeutics | EQUITIES | 103 | $3,019,500 | 50,000 | 0.00 | 50,000 | +Inf | 12-31-2023 | |
CymaBay Therapeutics Inc | LONG OPTION CALLS | Liquidated | $0 | 0 | 0.00 | 200,000 | +Inf | 12-31-2023 |